Medicus Pharma (MDCX) Competitors $3.13 -0.17 (-5.15%) As of 03/28/2025 03:57 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock MDCX vs. TLSA, ACTU, EPRX, CGEN, GNLX, ENTA, MGNX, MCRB, OGI, and PRQRShould you be buying Medicus Pharma stock or one of its competitors? The main competitors of Medicus Pharma include Tiziana Life Sciences (TLSA), Actuate Therapeutics (ACTU), Eupraxia Pharmaceuticals (EPRX), Compugen (CGEN), Genelux (GNLX), Enanta Pharmaceuticals (ENTA), MacroGenics (MGNX), Seres Therapeutics (MCRB), Organigram (OGI), and ProQR Therapeutics (PRQR). These companies are all part of the "pharmaceutical products" industry. Medicus Pharma vs. Tiziana Life Sciences Actuate Therapeutics Eupraxia Pharmaceuticals Compugen Genelux Enanta Pharmaceuticals MacroGenics Seres Therapeutics Organigram ProQR Therapeutics Medicus Pharma (NASDAQ:MDCX) and Tiziana Life Sciences (NASDAQ:TLSA) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, institutional ownership, valuation, earnings, profitability, analyst recommendations, dividends, media sentiment and risk. Is MDCX or TLSA more profitable? Company Net Margins Return on Equity Return on Assets Medicus PharmaN/A N/A N/A Tiziana Life Sciences N/A N/A N/A Does the MarketBeat Community believe in MDCX or TLSA? Tiziana Life Sciences received 94 more outperform votes than Medicus Pharma when rated by MarketBeat users. However, 100.00% of users gave Medicus Pharma an outperform vote while only 63.58% of users gave Tiziana Life Sciences an outperform vote. CompanyUnderperformOutperformMedicus PharmaOutperform Votes2100.00% Underperform VotesNo VotesTiziana Life SciencesOutperform Votes9663.58% Underperform Votes5536.42% Do analysts rate MDCX or TLSA? Medicus Pharma presently has a consensus target price of $10.00, indicating a potential upside of 219.49%. Given Medicus Pharma's stronger consensus rating and higher possible upside, equities analysts clearly believe Medicus Pharma is more favorable than Tiziana Life Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Medicus Pharma 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50Tiziana Life Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has stronger valuation & earnings, MDCX or TLSA? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMedicus PharmaN/AN/AN/AN/AN/ATiziana Life SciencesN/AN/A-$17.69MN/AN/A Does the media prefer MDCX or TLSA? In the previous week, Medicus Pharma and Medicus Pharma both had 4 articles in the media. Medicus Pharma's average media sentiment score of 0.63 beat Tiziana Life Sciences' score of 0.47 indicating that Medicus Pharma is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medicus Pharma 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Tiziana Life Sciences 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryMedicus Pharma beats Tiziana Life Sciences on 6 of the 7 factors compared between the two stocks. Remove Ads Get Medicus Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for MDCX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MDCX vs. The Competition Export to ExcelMetricMedicus PharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$37.32M$6.90B$5.63B$7.83BDividend YieldN/A2.74%4.57%4.01%P/E RatioN/A7.1723.3318.67Price / SalesN/A220.47388.3491.01Price / CashN/A65.6738.1634.64Price / BookN/A6.396.894.23Net IncomeN/A$142.12M$3.20B$247.15M7 Day Performance-5.72%-5.06%-2.98%-2.17%1 Month Performance-21.55%-7.49%1.63%-5.68%1 Year PerformanceN/A-10.91%9.44%-0.74% Medicus Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MDCXMedicus PharmaN/A$3.13-5.2%$10.00+219.5%N/A$37.32MN/A0.00N/AEarnings ReportGap UpTLSATiziana Life Sciences0.6148 of 5 stars$1.39-8.9%N/A+146.7%$145.97MN/A0.008Short Interest ↑Gap UpACTUActuate TherapeuticsN/A$7.35-1.5%$20.00+172.1%N/A$143.56MN/A0.0010Gap DownEPRXEupraxia Pharmaceuticals2.5754 of 5 stars$4.02-2.9%$10.50+161.2%N/A$143.30MN/A-5.5829Gap DownCGENCompugen2.0224 of 5 stars$1.58+0.6%$4.00+153.2%-40.7%$140.99M$27.86M79.0070Positive NewsGNLXGenelux1.4628 of 5 stars$4.00+8.1%$18.25+356.3%-52.1%$138.15M$8,000.00-4.2110Earnings ReportUpcoming EarningsAnalyst ForecastAnalyst RevisionNews CoverageENTAEnanta Pharmaceuticals4.0007 of 5 stars$6.44+2.2%$17.25+167.9%-67.3%$137.39M$66.59M-1.30160MGNXMacroGenics3.8781 of 5 stars$2.18+6.3%$7.63+249.8%-91.4%$136.82M$139.77M-1.38430Analyst ForecastAnalyst RevisionMCRBSeres Therapeutics3.3481 of 5 stars$0.78+4.4%$4.00+413.1%-6.9%$135.74M$126.33M-3.39330Analyst RevisionPositive NewsOGIOrganigram0.6988 of 5 stars$1.08+0.9%N/A-52.1%$135.05M$166.12M-2.84860Positive NewsPRQRProQR Therapeutics1.9789 of 5 stars$1.63-0.6%$9.50+482.8%-38.3%$133.14M$18.91M-5.09180Analyst RevisionPositive NewsGap Up Remove Ads Related Companies and Tools Related Companies Tiziana Life Sciences Alternatives Actuate Therapeutics Alternatives Eupraxia Pharmaceuticals Alternatives Compugen Alternatives Genelux Alternatives Enanta Pharmaceuticals Alternatives MacroGenics Alternatives Seres Therapeutics Alternatives Organigram Alternatives ProQR Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MDCX) was last updated on 3/29/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medicus Pharma Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medicus Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
